American Oriental Bioengineering, Inc. (AOBI)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2012 | -781.24 USD | 14.82% |
| 2011 | -917.11 USD | -581.73% |
| 2010 | 190.38 USD | -82.88% |
| 2009 | 1112.22 USD | 79.03% |
| 2008 | 621.24 USD | 0.0% |
| 2007 | 621.24 USD | 31.91% |
| 2006 | 470.94 USD | 51.61% |
| 2005 | 310.62 USD | 34.78% |
| 2004 | 230.46 USD | 53.33% |
| 2003 | 150.30 USD | 36.36% |
| 2002 | 110.22 USD | 351.17% |
| 2001 | 24.43 USD | 101.45% |
| 2000 | -1679.94 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2013 Q1 | -288.69 USD | 40.56% |
| 2013 Q3 | -290.36 USD | -64.72% |
| 2013 Q2 | -176.28 USD | 38.94% |
| 2012 Q1 | -217.74 USD | 79.29% |
| 2012 FY | - USD | 14.82% |
| 2012 Q4 | -485.66 USD | -290.07% |
| 2012 Q3 | 255.51 USD | 177.75% |
| 2012 Q2 | -328.65 USD | -50.94% |
| 2011 Q4 | -1051.57 USD | -1149.47% |
| 2011 FY | - USD | -581.73% |
| 2011 Q3 | 100.20 USD | 185.71% |
| 2011 Q2 | 35.07 USD | 250.0% |
| 2011 Q1 | 10.02 USD | -50.0% |
| 2010 Q2 | 70.14 USD | 75.0% |
| 2010 Q3 | 60.12 USD | -14.29% |
| 2010 Q4 | 20.04 USD | -66.67% |
| 2010 Q1 | 40.08 USD | -94.37% |
| 2010 FY | - USD | -82.88% |
| 2009 Q2 | 170.34 USD | 54.55% |
| 2009 FY | - USD | 79.03% |
| 2009 Q4 | 711.42 USD | 446.15% |
| 2009 Q1 | 110.22 USD | 10.0% |
| 2009 Q3 | 130.26 USD | -23.53% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | 120.24 USD | -42.86% |
| 2008 Q4 | 100.20 USD | -54.55% |
| 2008 Q3 | 220.44 USD | 22.22% |
| 2008 Q2 | 180.36 USD | 50.0% |
| 2007 Q3 | 160.32 USD | 6.67% |
| 2007 Q4 | 210.42 USD | 31.25% |
| 2007 Q1 | 100.20 USD | -41.18% |
| 2007 FY | - USD | 31.91% |
| 2007 Q2 | 150.30 USD | 50.0% |
| 2006 Q4 | 170.34 USD | 41.67% |
| 2006 FY | - USD | 51.61% |
| 2006 Q3 | 120.24 USD | 33.33% |
| 2006 Q2 | 90.18 USD | 12.5% |
| 2006 Q1 | 80.16 USD | -11.11% |
| 2005 Q4 | 90.18 USD | 12.5% |
| 2005 Q1 | 50.10 USD | -37.5% |
| 2005 Q2 | 80.16 USD | 60.0% |
| 2005 Q3 | 80.16 USD | 0.0% |
| 2005 FY | - USD | 34.78% |
| 2004 Q3 | 70.14 USD | 40.0% |
| 2004 Q2 | 50.10 USD | 25.0% |
| 2004 Q1 | 40.08 USD | 100.0% |
| 2004 FY | - USD | 53.33% |
| 2004 Q4 | 80.16 USD | 14.29% |
| 2003 Q4 | 20.04 USD | -50.0% |
| 2003 Q1 | 60.12 USD | 100.0% |
| 2003 Q2 | 40.08 USD | -33.33% |
| 2003 Q3 | 40.08 USD | 0.0% |
| 2003 FY | - USD | 36.36% |
| 2002 Q3 | 30.06 USD | 263.73% |
| 2002 Q1 | 70.14 USD | 250.0% |
| 2002 FY | - USD | 351.17% |
| 2002 Q4 | 30.06 USD | 0.0% |
| 2002 Q2 | -18.36 USD | -126.18% |
| 2001 Q2 | 213.35 USD | 164.01% |
| 2001 FY | - USD | 101.45% |
| 2001 Q4 | 20.04 USD | 485.38% |
| 2001 Q3 | -5.20 USD | -102.44% |
| 2001 Q1 | -333.32 USD | 12.79% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | -1296.37 USD | 0.0% |
| 2000 Q2 | -471.56 USD | 63.62% |
| 2000 Q3 | 431.53 USD | 191.51% |
| 2000 Q4 | -382.21 USD | -188.57% |
| Name | Eps | Eps Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -0.01 USD | -7659115.686% |
| Arch Therapeutics, Inc. | -2.27 USD | -34315.859% |
| Evofem Biosciences, Inc. | 10.35 USD | 7648.213% |
| Nascent Biotech, Inc. | -0.01 USD | -5830049.254% |
| Rebus Holdings, Inc. | -0.03 USD | -2433669.47% |
| Santhera Pharmaceuticals Holding AG | 5.95 USD | 13230.084% |
| Qrons Inc. | -0.06 USD | -1339934.305% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -0.00 USD | -52082566.667% |
| Northwest Biotherapeutics, Inc. | -0.06 USD | -1358578.261% |
| ProtoKinetix, Incorporated | -0.01 USD | -7812300.0% |
| Skye Bioscience, Inc. | -5.37 USD | -14448.231% |
| Eiger BioPharmaceuticals, Inc. | -50.78 USD | -1438.48% |
| Nanobac Pharmaceuticals, Incorporated | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -0.05 USD | -1516870.874% |
| SQZ Biotechnologies Company | -2.76 USD | -28205.797% |
| Intellipharmaceutics International Inc. | -0.09 USD | -893767.277% |
| Propanc Biopharma, Inc. | -0.02 USD | -3296271.308% |
| Mesoblast Limited | -0.09 USD | -876712.57% |
| Marizyme, Inc. | -1.44 USD | -54152.778% |
| Genus plc | 0.12 USD | 651133.333% |
| VioQuest Pharmaceuticals, Inc. | -2.33 USD | -33429.614% |
| Pharming Group N.V. | -0.02 USD | -4852322.36% |
| Therapeutic Solutions International, Inc. | -0.00 USD | -111605614.286% |
| CNBX Pharmaceuticals Inc. | -0.42 USD | -185909.524% |
| Nymox Pharmaceutical Corporation | -0.10 USD | -809475.13% |
| ContraFect Corporation | -124.97 USD | -525.142% |
| PsyBio Therapeutics Corp. | -0.04 USD | -1859995.238% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -0.01 USD | -6510233.333% |
| IMV Inc. | -4.37 USD | -17777.346% |
| AXIM Biotechnologies, Inc. | -0.04 USD | -2206792.655% |
| MultiCell Technologies, Inc. | -0.00 USD | -781239900.0% |
| ONE Bio Corp. | 1.43 USD | 54732.168% |
| Accustem Sciences Inc. | -0.34 USD | -229676.471% |
| RVL Pharmaceuticals plc | -0.58 USD | -134596.552% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -0.12 USD | -650933.333% |
| Q BioMed Inc. | -0.08 USD | -1000207.298% |
| Emmaus Life Sciences, Inc. | -0.07 USD | -1111194.452% |
| Mosaic ImmunoEngineering Inc. | -0.33 USD | -236639.394% |
| Biomind Labs Inc. | -0.02 USD | -4822369.136% |
| Provectus Biopharmaceuticals, Inc. | -0.01 USD | -10557197.297% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -0.02 USD | -3925729.146% |
| GlobeStar Therapeutics Corporation | -0.00 USD | -32551566.667% |
| THC Farmaceuticals, Inc. | -0.00 USD | -97654900.0% |
| Acro Biomedical Co., Ltd. | -0.26 USD | -300376.923% |
| Curative Biotechnology, Inc. | -0.01 USD | -8877627.273% |
| GB Sciences, Inc. | -0.00 USD | -19054534.146% |
| Alpha Cognition Inc. | -0.15 USD | -520726.667% |
| HST Global, Inc. | -0.03 USD | -2800043.369% |
| CSL Limited | 2.73 USD | 28716.85% |
| Wesana Health Holdings Inc. | -0.05 USD | -1559261.277% |
| Halberd Corporation | -0.00 USD | -781239900.0% |
| Enzolytics Inc. | -0.00 USD | -111605614.286% |
| Agentix Corp. | -0.04 USD | -2232014.286% |
| Resverlogix Corp. | -0.01 USD | -5501590.141% |
| Nuo Therapeutics, Inc. | -0.08 USD | -1036027.321% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -5.16 USD | -15040.31% |
| Enzon Pharmaceuticals, Inc. | 0.00 USD | 60095484.615% |
| Endonovo Therapeutics, Inc. | 0.03 USD | 3112609.96% |
| RespireRx Pharmaceuticals Inc. | -0.04 USD | -2188247.339% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -0.02 USD | -3906100.0% |
| AVAX Technologies, Inc. | -0.05 USD | -1449324.861% |
| Zenith Capital Corp. | -0.07 USD | -1117553.791% |
| Genscript Biotech Corporation | -0.05 USD | -1720692.952% |
| Ember Therapeutics, Inc. | -0.01 USD | -12400534.921% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -3.77 USD | -20622.546% |
| WPD Pharmaceuticals Inc. | -0.00 USD | -156247900.0% |
| Cotinga Pharmaceuticals Inc. | -0.09 USD | -855584.556% |
| Kadimastem Ltd | -0.78 USD | -100058.974% |
| Helix BioMedix, Inc. | -4.70 USD | -16522.128% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -36.39 USD | -2046.854% |
| BioStem Technologies, Inc. | -0.62 USD | -125906.452% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -0.01 USD | -6564942.017% |
| LadRx Corporation | 0.68 USD | 114988.235% |
| Cell Source, Inc. | -0.17 USD | -459452.941% |
| Regen BioPharma, Inc. | 0.29 USD | 269493.103% |
| Regen BioPharma, Inc. | 0.26 USD | 300576.923% |
| NovAccess Global Inc. | -0.23 USD | -339569.565% |
| Affymax, Inc. | -0.39 USD | -200217.949% |
| Itoco Inc. | -0.01 USD | -10279373.684% |
| Rasna Therapeutics, Inc. | -0.01 USD | -7812300.0% |
| Pathfinder Cell Therapy, Inc. | -0.00 USD | -31249500.0% |
| Mobile Lads Corp. | -0.01 USD | -13950614.286% |
| CytoDyn Inc. | -0.05 USD | -1476724.197% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -0.00 USD | -156247900.0% |
| NanoSphere Health Sciences Inc. | -0.02 USD | -3518999.099% |
| Alseres Pharmaceuticals, Inc. | -153.67 USD | -408.388% |
| SYBLEU INC | -0.02 USD | -4464128.571% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -0.01 USD | -5501590.141% |
| International Stem Cell Corporation | -0.02 USD | -4763558.537% |
| Bioxytran, Inc. | -0.03 USD | -2448928.213% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -0.00 USD | -781239900.0% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -7.99 USD | -9677.722% |
| Adhera Therapeutics, Inc. | -1.18 USD | -66106.78% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -0.03 USD | -2297664.706% |
| Innovation Pharmaceuticals Inc. | -0.01 USD | -12400534.921% |
| Neutra Corp. | -0.00 USD | -781239900.0% |
| Windtree Therapeutics, Inc. | -94.23 USD | -729.078% |
| PureTech Health plc | -2.38 USD | -32725.21% |
| Coeptis Therapeutics, Inc. | -0.83 USD | -94025.301% |
| IXICO plc | -0.02 USD | -3201703.279% |
| IntelGenx Technologies Corp. | -0.06 USD | -1375322.535% |
| Gelesis Holdings, Inc. | -1.35 USD | -57769.63% |
| CSL Limited | 5.47 USD | 14382.267% |
| Cellectis S.A. | -1.77 USD | -44037.853% |